New Releases from NCBI BookshelfBelumosudil for treating chronic graft-versus-host disease after 2 or more systemic treatments in people 12 years and over.​Belumosudil for treating chronic graft-versus-host disease after 2 or more systemic treatments in people 12 years and over.